Lv4
538 积分 2024-05-14 加入
Pharmacokinetics of sugammadex in subjects with moderate and severe renal impairment
10天前
已完结
Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision
1个月前
已完结
Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents III: The 2023 Geneva revision
1个月前
已完结
Reversal of Profound Rocuronium-induced Blockade with Sugammadex: A Randomized Comparison with Neostigmine
2个月前
已完结
Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial
2个月前
已完结
Sugammadex Provides Faster Reversal of Vecuronium-Induced Neuromuscular Blockade Compared with Neostigmine: A Multicenter, Randomized, Controlled Trial
2个月前
已完结
A pharmacovigilance study of FDA adverse events for sugammadex
2个月前
已完结
Systematic analysis of sugammadex-related adverse drug reaction signals using FAERS database
2个月前
已完结
A real-world pharmacovigilance study of cardiac adverse events induced by sugammadex in the FDA adverse event reporting system
2个月前
已完结
A Novel Concept of Reversing Neuromuscular Block: Chemical Encapsulation of Rocuronium Bromide by a Cyclodextrin-Based Synthetic Host
2个月前
已完结
皖公网安备34019202002308
